Our results showed that IL-13 treatment significantly decreased the time needed to remove the adhesive from the contralateral front paw in the late stage after ischemic stroke, at 14 dpi (Fig. 5a, p = 0.0345). This evidence concerns the gene IL13 and ischemic stroke.